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Metallo-b-lactamases produced by
carbapenem-resistant Pseudomonas
aeruginosa in Brazil
The recent article by Sader et al. [1] reported the
production of three metallo-b-lactamase (MBL)
types, i.e., SPM-1-like, VIM-2-like and IMP-1-like
MBLs, by carbapenem-resistant Pseudomonas
aeruginosa isolates from a hospital in Sa˜o Paulo,
Brazil in 2000–2001. The authors stated that the
production of MBLs in P. aeruginosa isolates is
becoming common in Brazil and other Latin
American countries. However, Poirel et al. [2]
analysed carbapenem-resistant P. aeruginosa iso-
lates recovered from different hospitals in Recife,
Brazil between November 2002 and January 2003,
and only identified the blaSPM-1 gene. Carbapen-
ems are often used as a last resort for treating
serious infections attributable to multidrug-resist-
ant Gram-negative bacilli, especially P. aeruginosa,
because these drugs are stable even in the
presence of extended-spectrum and AmpC
b-lactamases. However, production of MBLs has
increasingly been reported as a cause of high-
level carbapenem resistance in P. aeruginosa.
MBLs belonging to the major IMP and VIM
types emerged and spread during the early
1990s, and their variants have been recognised
worldwide, including in Brazil. Two other MBL
types, SPM-1 and GIM-1, appear, to date, to be
restricted in P. aeruginosa to Brazil and Germany,
respectively [3].
In order to determine the occurrence of MBLs
in P. aeruginosa isolates from clinical settings in
the northeastern Amazon region (Sa˜o Luı´s do
Maranha˜o, Brazil), 80 imipenem-resistant P. aeru-
ginosa isolates from 2000 to 2002 were screened for
the presence of genes encoding MBLs of the VIM,
IMP and SPM types. Six isolates from 2002 were
blaSPM-positive. The blaSPM amplicons were seq-
uenced to confirm the presence of the SPM-1 gene
(DQ145284). In contrast to Sa˜o Paulo, neither
blaVIM nor blaIMP genes were found in this north-
eastern region of Brazil. SPM-1 producers
emerged in Sa˜o Paulo in 1997, and some isolates
of this clone have been observed in other areas of
Brazil, as opposed to VIM and IMP, which have
been detected only in Sa˜o Paulo. In Japan, the
only country where MBL surveillance pro-
grammes have been conducted for VIM, IMP
and SPM, the blaSPM gene has not yet been found.
The emergence of blaSPM-1 in the Amazon region
shows its rapid dissemination within Brazil,
suggesting possible mobilisation of this gene or
the epidemic spread of a particular resistant
clone. Interestingly, there is no evidence that this
gene is associated with mobile genetic elements
such as transposons and plasmids. Nevertheless,
Poirel et al. [2] provided evidence for a putative
genetic element that may play a role in blaSPM-1
dissemination. Fortunately, blaIMP and blaVIM,
both of which are associated with transmissible
genetic elements and have already been detected
in Sa˜o Paulo and worldwide, do not yet appear to
have emerged in the northeastern region of Brazil.
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